Solesence, Inc.

SLSN Consumer Defensive Household & Personal Products

Solesence, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.1 million, up 18.6% from fiscal 2024.

Revenue
−24.7%
EPS
−105.5%
Free cash flow
+86.5%
Total debt
+36.1%

Quarter to June 2026, against a year earlier

0.87 0.02 +2.35%
Market cap
$60.1M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
2/9
Altman Z
1.02
Beneish M
−1.13
Dividend safety
n/a

Insider Decisions last twelve months

Bought, $m 0.00
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy 1 — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 74.05%

Capital & Financial Ratios $m

Size
Market Cap 60.06
Revenue ttm 55.37
Net income ttm (2.91)
Free cash flow ttm (0.85)
Net debt Q 13.24
Valuation
P/E 0.00
Forward P/E —
Price / sales 1.11
Forward P/S Powerpack
Price / FCF 0.00
Price / book 4.67
Financial health
Current ratio Q 0.97 (below 1: weak)
Debt / equity Q 1.09
Interest coverage Q 0.43
Growth
Revenue growth Q −24.69% (below 0%: shrinking)
Operating income growth Q −95.11% (below 0%: shrinking)
EPS, this year —
EPS, next year A —
Revenue, next year A —
EPS, past 5 yrs −7.79% (below 0%: weak)
EPS, next 5 yrs A —

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/S against its own 10 years 14.46%
10-year low 10-year high
P/B against its own 10 years 8.11%
10-year low 10-year high
EV/Sales against its own 10 years 31.72%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 2 1 1 1
Receivables 3 5 7 9
Inventory 10 20 19 13
Other — — — —
16 29 29 25
2023 2024 2025 Q'26
Payables 6 9 4 5
ST’ Debt 5 5 5 14
Other — — — —
16 26 14 26

Compound Annual Growth %

10y 5y 3y
Sales 19.66% 29.38% 18.48%
Cash Flow 0.00% 0.00% 0.00%
Earnings 0.00% 12.60% 0.00%
Book Value 19.95% 45.20% 46.15%

EPS $

Mar Jun Sep Dec Year
’26 (0.01) 0.00 — — —
’25 0.00 0.04 (0.02) (0.01) 0.02
’24 0.02 0.01 0.04 (0.01) 0.07
’23 (0.02) 0.01 (0.03) (0.04) (0.09)
’22 0.00 0.00 (0.02) (0.04) (0.05)
’21 0.03 0.00 0.03 (0.01) 0.05
’20 0.00 0.01 0.01 0.00 0.03
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 13 15 — — —
’25 15 20 15 12 62
’24 10 13 17 13 52
’23 9 12 8 8 37
’22 8 11 10 8 37
’21 7 7 8 7 29
’20 4 4 4 5 17
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 2 0 — — —
’25 (7) (1) (3) 2 (9)
’24 (4) (1) 4 2 2
’23 (1) (1) 3 (3) (2)
’22 (2) (2) 1 1 (2)
’21 0 1 0 2 2
’20 (1) 0 0 0 (2)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 1 0 — — —
’25 (7) (2) (3) 1 (11)
’24 (4) (1) 3 0 (3)
’23 (1) (2) 3 (3) (3)
’22 (2) (2) 0 0 (4)
’21 0 0 (1) 2 0
’20 (1) 0 (1) (1) (3)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 11 12 14 13 17 29 37 37 52 62 55 +21.5% — — — —
Gross margin, % 30.05 30.87 23.18 20.91 34.98 29.48 22.40 20.98 30.92 25.88 25.87 (4.2) pt
EBT (1) (1) (2) (3) 1 2 (3) (4) 4 2 (3) n/m
EBT margin, % (11.90) (6.33) (14.66) (24.03) 5.78 8.00 (7.07) (11.75) 8.52 3.00 (4.99) +14.9 pt
Net income (1) (1) (2) (3) 1 2 (3) (4) 4 2 (3) n/m
Per share, $
Per share, $ Revenue 0.35 0.40 0.42 0.34 0.45 0.65 0.76 0.75 0.84 0.88 0.78 +10.9%
Earnings (0.04) (0.03) (0.06) (0.08) 0.03 0.05 (0.05) (0.09) 0.07 0.03 (0.03) n/m
Cash flow (0.01) (0.03) (0.04) (0.08) (0.05) 0.05 (0.03) (0.04) 0.03 (0.12) 0.01 +35.7%
Capex (0.01) 0.00 0.00 (0.02) (0.02) (0.04) (0.06) (0.02) (0.07) (0.03) (0.03) +21.5%
Free cash flow (0.01) (0.03) (0.04) (0.10) (0.08) 0.01 (0.09) (0.06) (0.04) (0.15) (0.01) +31.3%
Book value 0.09 0.10 0.04 0.04 0.07 0.17 0.12 0.04 0.24 0.25 0.19 +12.0%
Shares, m 31 31 34 37 38 45 49 50 62 70 71 +9.6%
Valuation, ×
Valuation, × P/E 0.00 0.00 0.00 0.00 34.55 79.71 0.00 0.00 37.48 82.90 0.00 23.5
P/S 2.06 1.31 1.74 0.82 1.89 6.72 1.49 0.80 2.91 1.81 1.11 2.2
P/B 7.97 5.04 17.87 6.78 11.87 26.54 9.83 15.63 10.18 7.99 4.67 12.0
EV/Sales 1.93 1.20 1.73 0.85 1.99 6.77 1.65 1.04 3.09 2.04 1.54 2.2
EV/FCF (51.20) (14.49) (16.37) (3.03) (11.62) 446.18 (13.77) (12.70) (62.59) (11.81) (100.35) 24.9
Cash, $m
Cash, $m Operating cash flow 0 (1) (1) (3) (2) 2 (2) (2) 2 (9) 1 +48.7%
Capex 0 0 0 (1) (1) (2) (3) (1) (5) (2) (2) +33.0%
Free cash flow 0 (1) (2) (4) (3) 0 (4) (3) (3) (11) (1) +43.9%
Balance, $m
Balance, $m Working capital 2 3 1 1 2 4 3 1 4 15 (1) +24.1%
Net debt (2) (2) 0 0 2 0 6 9 4 14 13 n/m
Shareholders’ equity 3 3 1 2 3 7 6 2 15 18 13 +22.7%
Returns, %
Returns, % ROA (27.25) (14.21) (32.43) (37.71) 8.63 11.07 (8.47) (13.22) 10.22 3.58 (4.60) +30.8 pt
ROIC (70.63) (28.50) (120.99) (90.31) 20.93 20.47 (12.02) (20.17) 17.30 3.11 (3.65) +73.7 pt
ROE (45.40) (26.20) (90.16) (207.67) 46.62 45.50 (40.00) (116.28) 50.27 10.99 (15.61) +56.4 pt
People
People Employees 46 48 54 53 54 58 82 79 98 115 — +10.7%
Revenue/emp, $m 0.23 0.26 0.26 0.24 0.32 0.51 0.46 0.47 0.53 0.54 — +9.7%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Solesence, Inc. vs peers in Household & Personal Products (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ACU Acme United Corporation. $257.9M 26.9× 25.5× +16.15% (above 0%: growing) +4.76% (above 0%: growing) +155.61% (above 0%: growing) 42.55% 10.89% Compare
NUS Nu Skin Enterprises, Inc. $226.4M — (loss-making) — (loss-making) −17.10% (below 0%: shrinking) n/m −86.06% (below 0%: shrinking) 68.20% (18.53%) Compare
YSG Yatsen Holding Limited Sponsored ADR $143.5M — (loss-making) — (loss-making) +10.97% (above 0%: growing) n/m +14.56% (above 0%: growing) 73.88% (11.55%) Compare
SKIN SkinHealth Systems Inc. $64.7M — (loss-making) — (loss-making) −7.77% (below 0%: shrinking) n/m −81.89% (below 0%: shrinking) 68.42% 4.95% Compare
SLSN Solesence, Inc. $60.1M — (loss-making) — −24.69% (below 0%: shrinking) n/m +86.52% (above 0%: growing) 30.97% 0.79%
GROV Grove Collaborative Holdings, Inc. $46.5M — (loss-making) — (loss-making) −16.94% (below 0%: shrinking) n/m +101.08% (above 0%: growing) 53.56% (2.14%) Compare
UG United-Guardian, Inc. $32.5M 13.4× 18.7× +9.52% (above 0%: growing) +14.29% (above 0%: growing) +428.43% (above 0%: growing) 49.73% 24.26% Compare
DSY Big Tree Cloud Holdings Limited $15.1M 18.1× — — 0.00% −267.22% (below 0%: shrinking) — — Compare
ATTT Atlas Trinity Tech Limited $13.9M — — — — −192.00% (below 0%: shrinking) — — Compare
Median of peers $55.6M 18.1× — +0.88% +4.76% −33.66% 60.88% 1.41%

All 31 Household & Personal Products stocks →

Pay and ownership Proxy statement filed 30 July 2025

Ownership

Directors and executive officers, together 4.80%
Bradford T. Whitmore 70.70%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Solesence, Inc. (SLSN) Latest News

1 Jun

Impact 3 · · The Motley Fool transcript

11 Nov

Impact 4 · · The Motley Fool transcript
Impact 4 · · GlobeNewswire

7 Nov

3 Nov

Impact 4 · · Simply Wall St.

27 Oct

Impact 4 · · Simply Wall St.
Impact 4 · · Simply Wall St.

16 Oct

Impact 4 · · Simply Wall St.

13 Oct

Impact 4 · · Simply Wall St.

6 Oct

Impact 4 · · Simply Wall St.

30 Sep

Impact 4 · · Simply Wall St.
Impact 4 · · Simply Wall St.
stockrow.com/SLSN · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com